Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-10-06 | Sold | €9.03 | — |
| 2026-10-05 | Sold | €9.03 | — |
| 2026-10-04 | Sold | €9.03 | — |
| 2026-10-03 | Sold | €9.03 | — |
| 2026-10-02 | Sold | €9.03 | — |
| 2026-10-01 | Sold | €9.03 | — |
| 2026-09-30 | Sold | €9.03 | — |
| 2026-09-29 | Sold | €9.03 | — |
| 2026-09-28 | Sold | €9.03 | — |
| 2026-09-27 | Sold | €9.03 | — |
| 2026-09-26 | Sold | €9.03 | — |
| 2026-09-25 | Sold | €9.03 | — |
| 2026-09-24 | Sold | €9.03 | — |
| 2026-09-23 | Sold | €9.03 | — |
Facing a New Trial / #040
France: lowest · Germany: above average · EU average €14.95Choose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
AggregatedRAW | €9.03 | €8.00 | €10.00 | 0.0% | >5 | |
NMRAW | €9.03 | €8.00 | €10.00 | 0.0% | >5 |
Explore Darkrai GX (sm2+ 040) Facing a New Trial JP #040, Normal from Facing a New Trial, with 413 price records for the EU market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.